Inventor · disambiguated record
Michael J. Orwat
Also filed as: ORWAT MICHAEL J · ORWAT MICHAEL JAMES
42 granted patents·15 pending applications·1,202 citations·filing 1993–2022
98Inventor score
Files withBRISTOL MYERS SQUIBB CO41DU PONT MERCK PHARMA6BRISTOL MYERS SQUIBB PHARMA CO4DU PONT PHARM CO4BRISTOL MYERS SQUIBB PHARMS CO1
Top patents by PatentIndex Score
57 records- 0198US6020357ANitrogen containing heteroaromatics as factor Xa inhibitorsDU PONT PHARM CO·Filed 1997·Granted Feb 1, 2000·353 cites·72 claims
- 0297US6989391B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Jan 24, 2006·59 cites·35 claims
- 0397US5593994AProstaglandin synthase inhibitorsDU PONT MERCK PHARMA·Filed 1994·Granted Jan 14, 1997·251 cites·13 claims
- 0496US9453018B2Pyrimidinones as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 27, 2016·13 cites·17 claims
- 0596US6967208B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2002·Granted Nov 22, 2005·100 cites·103 claims
- 0696US6548512B1Nitrogen containing heteroaromatics as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Apr 15, 2003·75 cites·52 claims
- 0795US8367709B2Dipeptide analogs as coagulation factor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Feb 5, 2013·42 cites·11 claims
- 0894US9192607B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Nov 24, 2015·7 cites·11 claims
- 0994US7371761B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 13, 2008·12 cites·26 claims
- 1094US7312214B21, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Dec 25, 2007·58 cites·31 claims
- 1193US9000172B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Apr 7, 2015·7 cites·19 claims
- 1292US7005435B2Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMA CO·Filed 2004·Granted Feb 28, 2006·19 cites·9 claims
- 1390US6750225B21,4,5,6-tetrahydropyrazolo-[3,4,-c]-pyridin-7-ones useful as factor Xa inhibitorsBRISTOL MYERS SQUIBB PHARMS CO·Filed 2002·Granted Jun 15, 2004·35 cites·65 claims
- 1489US9944625B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 17, 2018·3 cites·14 claims
- 1587US11053247B2Pyrimidinones as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 6, 2021·2 cites·9 claims
- 1686US10336754B2Pyrimidinones as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 2, 2019·2 cites·17 claims
- 1784US9108951B2Substituted 5,6,7,8-tetrahydro-1,6-naphthyridines as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Aug 18, 2015·5 cites·6 claims
- 1884US5639759ACarbocyclic and heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agentsDU PONT MERCK PHARMA·Filed 1995·Granted Jun 17, 1997·46 cites·16 claims
- 1983US7371864B2Crystalline forms of a factor Xa inhibitorBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 13, 2008·7 cites·23 claims
- 2079US10676477B2Factor XIa macrocycle inhibitors bearing a non-aromatic P2' groupBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 9, 2020·2 cites·12 claims
- 2179US9447110B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 20, 2016·1 cites·1 claims
- 2278US9777001B2Macrocycles with aromatic P2′ groups as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 3, 2017·3 cites·11 claims
- 2377US12428421B2Pyrimidinones as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 30, 2025·0 cites·31 claims
- 2477US10000466B2Substituted 4,5,6,7-tetrahydropyrazolo[3,4-c]pyridines as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 19, 2018·1 cites·5 claims
- 2573US10611776B2Spiroheptane salicylamides and related compounds as inhibitors of rockBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 7, 2020·1 cites·17 claims
- 2673US2020140436A1Lactam-containing compounds and derivatives thereof as factor xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2772US5874441ACarbocyclic and hetertocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agentsDU PONT PHARM CO·Filed 1997·Granted Feb 23, 1999·23 cites·19 claims
- 2869US10208021B2Substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 19, 2019·0 cites·3 claims
- 2969US2018244673A1Lactam-containing compounds and derivatives thereof as factor xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 3068US6110910ACarbocyclic heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agentsDU PONT PHARM CO·Filed 1998·Granted Aug 29, 2000·18 cites·16 claims
- 3166US9738655B2Tetrahydroisoquinolines containing substituted azoles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 22, 2017·1 cites·15 claims
- 3266US5932586AProstaglandin synthase inhibitorsDU PONT PHARM CO·Filed 1996·Granted Aug 3, 1999·21 cites·9 claims
- 3365US2014113892A1Lactam-containing compounds and derivatives thereof as factor xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 3463US2025049765A1Bicyclo [3.2.0] heptane bis(amide) rxfp1 agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 3563US2025100960A1Naphthalene and quinoline analogs as rxfp1 agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 3663US2025066344A1Benzothiazole, benzoisoxazole, and benzodioxole analogs as rxfp1 receptor agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 3762US2016318904A1Substituted tetrahydroisoquinoline compounds as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 3861US2016368923A1Pyrimidinones as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 3960US2005261287A1Lactam-containing compounds and derivatives thereof as factor Xa inhibitorsPINTO DONALD J·Filed 2005·Application pending·0 cites
- 4060US2015210691A1Lactam-containing compounds and derivatives thereof as factor xa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 4159US10273236B2Macrocyclic factor XIa inhibitors bearing heterocyclic groupsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 30, 2019·0 cites·11 claims
- 4259US5428040ACarbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agentsDU PONT MERCK PHARMA·Filed 1993·Granted Jun 27, 1995·10 cites·8 claims
- 4358US10829501B2Spiroheptane salicylamides and related compounds as inhibitors of ROCKBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Nov 10, 2020·0 cites·5 claims
- 4458US9725435B2Substituted 4,5,6,7-tetrahydropyrazolo[4,3-c]pyridines as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Aug 8, 2017·0 cites·5 claims
- 4558US2025011288A1Rxfp1 agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 4658US2025221966A1Rxfp1 agonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 4757US5416089APolycyclic and heterocyclic chromophores for bis-imide tumoricidalsDU PONT MERCK PHARMA·Filed 1993·Granted May 16, 1995·12 cites·15 claims
- 4855US9394276B2Substituted 1,2,3,4-tetrahydro-2,6-naphthyridines as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 19, 2016·0 cites·5 claims
- 4955US2008188517A1Crystalline forms of a factor xa inhibitorBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 5054US2017342071A1Macrocyclic factor xia inhibitors condensed with heterocyclesBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →